{"id":895508,"date":"2025-10-14T09:23:10","date_gmt":"2025-10-14T13:23:10","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/mallinckrodt-recognizes-first-hepatorenal-syndrome-hrs-awareness-day\/"},"modified":"2025-10-14T09:23:10","modified_gmt":"2025-10-14T13:23:10","slug":"mallinckrodt-recognizes-first-hepatorenal-syndrome-hrs-awareness-day","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/mallinckrodt-recognizes-first-hepatorenal-syndrome-hrs-awareness-day\/","title":{"rendered":"Mallinckrodt Recognizes First Hepatorenal Syndrome (HRS) Awareness Day"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p class=\"prntac\">\n        <i>\u2013 HRS Awareness Day will be observed annually on <span class=\"xn-chron\">October 14<\/span> during National Liver Awareness Month, with the goal of raising awareness around a life-threatening condition that occurs in people with advanced liver disease<sup>1<\/sup>\u2013<\/i>\n      <\/p>\n<p>\n        <span class=\"legendSpanClass\"><br \/>\n          <span class=\"xn-location\">DUBLIN<\/span><br \/>\n        <\/span>, <span class=\"legendSpanClass\"><span class=\"xn-chron\">Oct. 14, 2025<\/span><\/span> \/PRNewswire\/ &#8212; <a href=\"https:\/\/edge.prnewswire.com\/c\/link\/?t=0&amp;l=en&amp;o=4531743-1&amp;h=1486293601&amp;u=https%3A%2F%2Fwww.mnk-endo.com%2F&amp;a=Mallinckrodt+plc\" target=\"_blank\" rel=\"nofollow\"><span class=\"xn-org\">Mallinckrodt<\/span> plc<\/a>, a global specialty pharmaceutical company, today announced that the Company supports the inaugural Hepatorenal Syndrome (HRS) Awareness Day, established by the <a href=\"https:\/\/edge.prnewswire.com\/c\/link\/?t=0&amp;l=en&amp;o=4531743-1&amp;h=187552900&amp;u=https%3A%2F%2Fliverfoundation.org%2F&amp;a=American+Liver+Foundation+(ALF)\" target=\"_blank\" rel=\"nofollow\">American Liver Foundation (ALF)<\/a>.\u00a0HRS Awareness Day will be observed on <span class=\"xn-chron\">October 14<\/span> during National Liver Awareness Month. The purpose of this initiative is to promote increased awareness and education regarding HRS, including potential complications, the importance of early detection and treatment, and to honor the stories of HRS patients and their experiences.<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\">\n<p>\n          <a href=\"https:\/\/mma.prnewswire.com\/media\/167103\/mallinckrodt_plc_logo.html\" target=\"_blank\" rel=\"nofollow\"><br \/>\n            <img decoding=\"async\" src=\"https:\/\/mma.prnewswire.com\/media\/167103\/mallinckrodt_plc_logo.jpg\" title=\"Mallinckrodt logo\" alt=\"Mallinckrodt logo\" \/><br \/>\n          <\/a>\n        <\/p>\n<\/p><\/div>\n<p>HRS is classified into two distinct types \u2013 a rapidly progressive type that leads to renal failure where patients are typically hospitalized for their care (HRS-acute kidney injury (AKI)) and a more chronic type that progresses slowly over weeks to months (HRS-chronic kidney disease (CKD)).<sup>1,2<\/sup> HRS is estimated to affect more than 60,000 Americans annually, approximately 0.01% of the U.S. population,<sup>3<\/sup> making it a rare condition; and rates of HRS hospitalizations are increasing.<sup>4<\/sup><\/p>\n<p>&#8220;We&#8217;re proud to support this moment for the HRS community and help to raise visibility of this condition and the patients, care teams, and healthcare professionals it impacts,&#8221; said <b>Dr.\u00a0Marek Honczarenko, Executive Vice President and Chief Scientific Officer, <span class=\"xn-org\">Mallinckrodt<\/span>. <\/b>&#8220;U.S. physicians historically have faced significant challenges treating patients with HRS.&#8221;<\/p>\n<p>&#8220;HRS is a life-threatening complication of liver disease,<sup>1<\/sup>\u00a0so it is fitting to elevate knowledge about this condition and recognize those affected by it during National Liver Awareness Month,&#8221; said <b><span class=\"xn-person\">Lorraine Stiehl<\/span>, CEO, American Liver Foundation<\/b>. &#8220;Thank you to our sponsors, including <span class=\"xn-org\">Mallinckrodt<\/span>, who have made this awareness day possible and are committed to bringing treatment options to patients in need.&#8221;<\/p>\n<p>\n        <b>ABOUT\u00a0MALLINCKRODT<br \/><\/b><br \/>\n        <span class=\"xn-org\">Mallinckrodt<\/span> is dedicated to enhancing lives by providing therapeutics that strive to address unmet patient needs, and is a world-class manufacturer of high-quality generics, sterile injectables, and active pharmaceutical ingredients.<\/p>\n<p>Our company consists of multiple wholly owned subsidiaries that operate in two businesses. Our Brands business is focused on autoimmune and rare diseases in areas including endocrinology, gastroenterology, hepatology, neonatal respiratory critical care, nephrology, neurology, pulmonology, ophthalmology, orthopedics, rheumatology, and urology. Our Par Health business includes generic drugs, sterile injectables, and active pharmaceutical ingredients. To learn more, visit <a href=\"https:\/\/edge.prnewswire.com\/c\/link\/?t=0&amp;l=en&amp;o=4531743-1&amp;h=3196892943&amp;u=http%3A%2F%2Fwww.mnk-endo.com%2F&amp;a=www.MNK-Endo.com\" target=\"_blank\" rel=\"nofollow\">www.MNK-Endo.com<\/a>.<\/p>\n<p>\n        <b>CONTACT<\/b>\n      <\/p>\n<p>\n        <b><br \/>\n          <u>Media Inquiries<br \/><\/u><br \/>\n        <\/b>Green Room Communications<br \/>908-577-4531<br \/><a href=\"mailto:mediainquiries@grcomms.com\" target=\"_blank\" rel=\"nofollow\">mediainquiries@grcomms.com<\/a><\/p>\n<p>\n        <b><br \/>\n          <u>Investor Relations<br \/><\/u><br \/>\n        <\/b><br \/>\n        <span class=\"xn-person\">Juan Avendano<\/span><br \/>\n        <br \/>862-240-8194<br \/><a href=\"mailto:avendano.juan@endo.com\" target=\"_blank\" rel=\"nofollow\">avendano.juan@endo.com<\/a><\/p>\n<p>\n        <b><br \/>\n          <u>Patient Advocacy<br \/><\/u><br \/>\n        <\/b><br \/>\n        <span class=\"xn-person\">Derek Naten<\/span><br \/>\n        <br \/>202-257-5904<br \/><a href=\"mailto:derek.naten@mnk.com\" target=\"_blank\" rel=\"nofollow\">derek.naten@mnk.com<\/a><\/p>\n<p>\n        <span class=\"xn-org\">Mallinckrodt<\/span>, the &#8220;M&#8221; brand mark and the\u00a0Mallinckrodt Pharmaceuticals\u00a0logo are trademarks of a\u00a0Mallinckrodt\u00a0company. Other brands are trademarks of a\u00a0Mallinckrodt\u00a0company or their respective owners.<\/p>\n<p>\u00a92025 <span class=\"xn-org\">Mallinckrodt<\/span>. US-2500552 10\/25<\/p>\n<p>\n        <b>References<\/b>\n      <\/p>\n<p>\n        <sup>1<\/sup> National Organization for Rare Disorders. Hepatorenal Syndrome. Available at: <a href=\"https:\/\/edge.prnewswire.com\/c\/link\/?t=0&amp;l=en&amp;o=4531743-1&amp;h=3918013906&amp;u=https%3A%2F%2Frarediseases.org%2Frare-diseases%2Fhepatorenal-syndrome%2F&amp;a=https%3A%2F%2Frarediseases.org%2Frare-diseases%2Fhepatorenal-syndrome%2F\" target=\"_blank\" rel=\"nofollow\">https:\/\/rarediseases.org\/rare-diseases\/hepatorenal-syndrome\/<\/a>. Accessed <span class=\"xn-chron\">October 2025<\/span>.<br \/><sup>2<\/sup> Flamm S.L., Brown K., Wadei H.M., et al. The Current Management of Hepatorenal Syndrome\u2013Acute Kidney Injury in <span class=\"xn-location\">the United States<\/span> and the Potential of Terlipressin. <i>Liver Transpl<\/i>. 2021;27:1191-1202. <a href=\"https:\/\/edge.prnewswire.com\/c\/link\/?t=0&amp;l=en&amp;o=4531743-1&amp;h=2255236269&amp;u=https%3A%2F%2Fdoi.org%2F10.1002%2Flt.26072&amp;a=https%3A%2F%2Fdoi.org%2F10.1002%2Flt.26072\" target=\"_blank\" rel=\"nofollow\">https:\/\/doi.org\/10.1002\/lt.26072<\/a>.<br \/><sup>3<\/sup> United States Census Bureau: Quick Facts. Available at:\u00a0<a href=\"https:\/\/edge.prnewswire.com\/c\/link\/?t=0&amp;l=en&amp;o=4531743-1&amp;h=2981170369&amp;u=https%3A%2F%2Fc212.net%2Fc%2Flink%2F%3Ft%3D0%26l%3Den%26o%3D4001761-1%26h%3D82428179%26u%3Dhttps%253A%252F%252Fc212.net%252Fc%252Flink%252F%253Ft%253D0%2526l%253Den%2526o%253D3648954-1%2526h%253D4290173775%2526u%253Dhttps%25253A%25252F%25252Fwww.census.gov%25252Fquickfacts%25252Ffact%25252Ftable%25252FUS%25252FPST045218%2526a%253Dhttps%25253A%25252F%25252Fwww.census.gov%25252Fquickfacts%25252Ffact%25252Ftable%25252FUS%25252FPST045218%26a%3Dhttps%253A%252F%252Fwww.census.gov%252Fquickfacts%252Ffact%252Ftable%252FUS%252FPST045218&amp;a=https%3A%2F%2Fwww.census.gov%2Fquickfacts%2Ffact%2Ftable%2FUS%2FPST045218\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.census.gov\/quickfacts\/fact\/table\/US\/PST045218<\/a>. Accessed <span class=\"xn-chron\">October 2025<\/span>.<br \/><sup>4<\/sup> Wong R.J., Balasubramanain J., Panaccio M., et al. Acute Kidney Injury and Hepatorenal Syndrome Among Hospitalized Patients With Chronic Liver Disease. <i>JAMA Netw Open.\u00a0<\/i>2025;8(5):e2511816. doi:10.1001\/jamanetworkopen.2025.11816<\/p>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/edge.prnewswire.com\/c\/img\/favicon.png?sn=CG96812&amp;sd=2025-10-14\" \/> View original content to download multimedia:<a id=\"PRNURL\" rel=\"nofollow\" href=\"https:\/\/www.prnewswire.com\/news-releases\/mallinckrodt-recognizes-first-hepatorenal-syndrome-hrs-awareness-day-302582664.html\" target=\"_blank\">https:\/\/www.prnewswire.com\/news-releases\/mallinckrodt-recognizes-first-hepatorenal-syndrome-hrs-awareness-day-302582664.html<\/a><\/p>\n<p>SOURCE  <span class=\"xn-org\">Mallinckrodt<\/span> plc<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=CG96812&amp;Transmission_Id=202510140700PR_NEWS_USPR_____CG96812&amp;DateId=20251014\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire \u2013 HRS Awareness Day will be observed annually on October 14 during National Liver Awareness Month, with the goal of raising awareness around a life-threatening condition that occurs in people with advanced liver disease1\u2013 DUBLIN , Oct. 14, 2025 \/PRNewswire\/ &#8212; Mallinckrodt plc, a global specialty pharmaceutical company, today announced that the Company supports the inaugural Hepatorenal Syndrome (HRS) Awareness Day, established by the American Liver Foundation (ALF).\u00a0HRS Awareness Day will be observed on October 14 during National Liver Awareness Month. The purpose of this initiative is to promote increased awareness and education regarding HRS, including potential complications, the importance of early detection and treatment, and to honor the stories of HRS patients and their experiences. HRS is &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/mallinckrodt-recognizes-first-hepatorenal-syndrome-hrs-awareness-day\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Mallinckrodt Recognizes First Hepatorenal Syndrome (HRS) Awareness Day&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-895508","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Mallinckrodt Recognizes First Hepatorenal Syndrome (HRS) Awareness Day - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/mallinckrodt-recognizes-first-hepatorenal-syndrome-hrs-awareness-day\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Mallinckrodt Recognizes First Hepatorenal Syndrome (HRS) Awareness Day - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire \u2013 HRS Awareness Day will be observed annually on October 14 during National Liver Awareness Month, with the goal of raising awareness around a life-threatening condition that occurs in people with advanced liver disease1\u2013 DUBLIN , Oct. 14, 2025 \/PRNewswire\/ &#8212; Mallinckrodt plc, a global specialty pharmaceutical company, today announced that the Company supports the inaugural Hepatorenal Syndrome (HRS) Awareness Day, established by the American Liver Foundation (ALF).\u00a0HRS Awareness Day will be observed on October 14 during National Liver Awareness Month. The purpose of this initiative is to promote increased awareness and education regarding HRS, including potential complications, the importance of early detection and treatment, and to honor the stories of HRS patients and their experiences. HRS is &hellip; Continue reading &quot;Mallinckrodt Recognizes First Hepatorenal Syndrome (HRS) Awareness Day&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/mallinckrodt-recognizes-first-hepatorenal-syndrome-hrs-awareness-day\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-10-14T13:23:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/167103\/mallinckrodt_plc_logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mallinckrodt-recognizes-first-hepatorenal-syndrome-hrs-awareness-day\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mallinckrodt-recognizes-first-hepatorenal-syndrome-hrs-awareness-day\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Mallinckrodt Recognizes First Hepatorenal Syndrome (HRS) Awareness Day\",\"datePublished\":\"2025-10-14T13:23:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mallinckrodt-recognizes-first-hepatorenal-syndrome-hrs-awareness-day\\\/\"},\"wordCount\":575,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mallinckrodt-recognizes-first-hepatorenal-syndrome-hrs-awareness-day\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/167103\\\/mallinckrodt_plc_logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mallinckrodt-recognizes-first-hepatorenal-syndrome-hrs-awareness-day\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mallinckrodt-recognizes-first-hepatorenal-syndrome-hrs-awareness-day\\\/\",\"name\":\"Mallinckrodt Recognizes First Hepatorenal Syndrome (HRS) Awareness Day - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mallinckrodt-recognizes-first-hepatorenal-syndrome-hrs-awareness-day\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mallinckrodt-recognizes-first-hepatorenal-syndrome-hrs-awareness-day\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/167103\\\/mallinckrodt_plc_logo.jpg\",\"datePublished\":\"2025-10-14T13:23:10+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mallinckrodt-recognizes-first-hepatorenal-syndrome-hrs-awareness-day\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mallinckrodt-recognizes-first-hepatorenal-syndrome-hrs-awareness-day\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mallinckrodt-recognizes-first-hepatorenal-syndrome-hrs-awareness-day\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/167103\\\/mallinckrodt_plc_logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/167103\\\/mallinckrodt_plc_logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/mallinckrodt-recognizes-first-hepatorenal-syndrome-hrs-awareness-day\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Mallinckrodt Recognizes First Hepatorenal Syndrome (HRS) Awareness Day\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Mallinckrodt Recognizes First Hepatorenal Syndrome (HRS) Awareness Day - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/mallinckrodt-recognizes-first-hepatorenal-syndrome-hrs-awareness-day\/","og_locale":"en_US","og_type":"article","og_title":"Mallinckrodt Recognizes First Hepatorenal Syndrome (HRS) Awareness Day - Market Newsdesk","og_description":"PR Newswire \u2013 HRS Awareness Day will be observed annually on October 14 during National Liver Awareness Month, with the goal of raising awareness around a life-threatening condition that occurs in people with advanced liver disease1\u2013 DUBLIN , Oct. 14, 2025 \/PRNewswire\/ &#8212; Mallinckrodt plc, a global specialty pharmaceutical company, today announced that the Company supports the inaugural Hepatorenal Syndrome (HRS) Awareness Day, established by the American Liver Foundation (ALF).\u00a0HRS Awareness Day will be observed on October 14 during National Liver Awareness Month. The purpose of this initiative is to promote increased awareness and education regarding HRS, including potential complications, the importance of early detection and treatment, and to honor the stories of HRS patients and their experiences. HRS is &hellip; Continue reading \"Mallinckrodt Recognizes First Hepatorenal Syndrome (HRS) Awareness Day\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/mallinckrodt-recognizes-first-hepatorenal-syndrome-hrs-awareness-day\/","og_site_name":"Market Newsdesk","article_published_time":"2025-10-14T13:23:10+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/167103\/mallinckrodt_plc_logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mallinckrodt-recognizes-first-hepatorenal-syndrome-hrs-awareness-day\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mallinckrodt-recognizes-first-hepatorenal-syndrome-hrs-awareness-day\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Mallinckrodt Recognizes First Hepatorenal Syndrome (HRS) Awareness Day","datePublished":"2025-10-14T13:23:10+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mallinckrodt-recognizes-first-hepatorenal-syndrome-hrs-awareness-day\/"},"wordCount":575,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mallinckrodt-recognizes-first-hepatorenal-syndrome-hrs-awareness-day\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/167103\/mallinckrodt_plc_logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mallinckrodt-recognizes-first-hepatorenal-syndrome-hrs-awareness-day\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/mallinckrodt-recognizes-first-hepatorenal-syndrome-hrs-awareness-day\/","name":"Mallinckrodt Recognizes First Hepatorenal Syndrome (HRS) Awareness Day - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mallinckrodt-recognizes-first-hepatorenal-syndrome-hrs-awareness-day\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mallinckrodt-recognizes-first-hepatorenal-syndrome-hrs-awareness-day\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/167103\/mallinckrodt_plc_logo.jpg","datePublished":"2025-10-14T13:23:10+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mallinckrodt-recognizes-first-hepatorenal-syndrome-hrs-awareness-day\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/mallinckrodt-recognizes-first-hepatorenal-syndrome-hrs-awareness-day\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mallinckrodt-recognizes-first-hepatorenal-syndrome-hrs-awareness-day\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/167103\/mallinckrodt_plc_logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/167103\/mallinckrodt_plc_logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/mallinckrodt-recognizes-first-hepatorenal-syndrome-hrs-awareness-day\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Mallinckrodt Recognizes First Hepatorenal Syndrome (HRS) Awareness Day"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/895508","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=895508"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/895508\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=895508"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=895508"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=895508"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}